US equities
|
MU
$947.10
▼-4.24%
SNDK
$1,435.00
▼-3.52%
NVDA
$225.39
▼-0.41%
META
$747.32
▲+0.59%
AAPL
$346.12
▲+1.51%
MSFT
$549.13
▲+1.48%
SPCX
$159.85
▼-2.18%
AMD
$580.22
▼-2.36%
MU
$947.10
▼-4.24%
SNDK
$1,435.00
▼-3.52%
NVDA
$225.39
▼-0.41%
META
$747.32
▲+0.59%
AAPL
$346.12
▲+1.51%
MSFT
$549.13
▲+1.48%
SPCX
$159.85
▼-2.18%
AMD
$580.22
▼-2.36%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Sunshine Biopharma Inc. - Common stock
(NQ:
SBFM
)
0.2718
-0.0302 (-10.00%)
Delayed Quote
Updated: 9:40 AM EDT, Oct 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Sunshine Biopharma Inc. - Common stock
< Previous
1
2
3
Next >
Sunshine Biopharma Announces Closing of up to $20.4 Million Public Offering
October 09, 2026
$6.0 million upfront with an additional $14.4 million of potential aggregate gross proceeds upon the exercise of warrants
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
October 08, 2026
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio
September 24, 2026
Launch introduces ondansetron 4 mg and 8 mg tablets for nausea and vomiting associated with chemotherapy, radiation therapy and surgery Global ondansetron market projected to reach $2.98 billion by...
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
September 16, 2026
Nanomolar potency against PLpro with broad-spectrum SARS-CoV-2 variants activity Significant dose-dependent suppression of pulmonary viral replication in vivo Strong oral bioavailability and...
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions
August 31, 2026
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
August 26, 2026
EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:BNTX),(NYSE:AZN),(NASDAQ:MRNA),(NYSE:BMY) EQNX::TICKER_END
Via
FinancialNewsMedia
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
August 26, 2026
A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology
From
MarketNewsUpdates.com
Via
GlobeNewswire
Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer
August 26, 2026
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
August 19, 2026
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market
August 07, 2026
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
August 04, 2026
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
July 28, 2026
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Sunshine Biopharma and University of Arizona Publish Significant New Research Findings
July 20, 2026
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)
June 25, 2026
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)
June 01, 2026
Via
ACCESS Newswire
Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology
May 29, 2026
Via
ACCESS Newswire
Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing
May 28, 2026
Via
ACCESS Newswire
Stocks to Watch: NDRA, SBFM, GOVX, HIVE, ANY Trading Actively NOW!
May 26, 2026
Via
AB Newswire
Topics
Artificial Intelligence
ENDRA Life Sciences (NASDAQ: NDRA) Beats Q1 Expectations, TAEUS® Liver Imaging Advances and Strategic Review Acceleration Fuels Investor Awareness
May 26, 2026
Via
AB Newswire
Stocks Under $1: NXXT, TOON, VRAX, AIM, SBFM on Breakout Watch
May 26, 2026
Via
AB Newswire
Topics
Artificial Intelligence
Intellectual Property
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin
May 21, 2026
Via
ACCESS Newswire
BioMedNewsBreaks — Sunshine Biopharma Inc. (NASDAQ: SBFM) Closes $6 Million Public Offering
May 20, 2026
Via
Investor Brand Network
Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering
May 19, 2026
Via
ACCESS Newswire
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
May 18, 2026
Via
ACCESS Newswire
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year
April 06, 2026
Via
ACCESS Newswire
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
October 28, 2025
Via
ACCESS Newswire
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
October 28, 2025
Via
ACCESS Newswire
Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline
October 20, 2025
Via
ACCESS Newswire
Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin
October 16, 2025
Via
ACCESS Newswire
Sunshine Biopharma Stock is 34% Higher Since September as Investors Reward Performance Combined with Innovation (NASDAQ: SBFM)
October 16, 2025
Via
AB Newswire
< Previous
1
2
3
Next >
